What's Hot
View all perspectives
Dr. Rachel Tate uptoTate
4 years ago
Newly discovered HGF & HGFAC genes differentiate PsA and PsO in genetic analysis. Could these be important additional biomarkers for dz? #ABS0500 #ACR20 #ACRbest @RheumNow https://t.co/TNEQo6d6mk https://t.co/bQFBzYmV0J
sheila RHEUMarampa
4 years ago
ACPA+ and subclinical synovitis does not automatically mean developing to RA.
Interesting work by Cleo Rogier et al. Something to consider in pts w/arthralgias & when to start csDMARDs @RheumNow #ACR20 Abstr#481 #ACRbest https://t.co/q3vIITmtq2
CreakyJoints.org CreakyJoints
4 years ago
Lung disease in primary #SjogrensSyndrome is common; both conditions were diagnosed at the same time in 43% of patients, found an #ACR20 study from @joannamarco @GGRheumdoc + @UW @uofcincy colleagues. “Close monitoring is warranted” to make sure lung function is not declining. https://t.co/MpA0Rq2uVR
LiSa rheumarhyme
4 years ago
Timezones wont stop international attendees to make #rheum for knowledge at #ACR20. Watch to see @RHEUMarampa @RichardPAConway @drdavidliew interview @DrSwamyV 🌎🌍🌏
@RheumNow https://t.co/dbIjiLhUnh
David Liew drdavidliew
4 years ago
#ACR20 has a fantastic virtual platform & have put in a big effort to make the meeting friendly for international attendees.
I had a great chat about it with @DrSwamyV (@ACRheum Chair, Education) @RheumNow with @RichardPAConway @RHEUMarampa
Check it out: https://t.co/TDHg0PExBC
KenWarringtonMD MdWarrington
4 years ago
This convinces me! #TNF inhibitors vs #JAKI
great debate at #ACR20 https://t.co/Xb8KkmDJ8f
Dr. Antoni Chan synovialjoints
4 years ago
New treatments in Axial Spa at #ACR20. A significantly higher proportion of pts receiving Upadactinib vs placebo achieved reductions in all PGA of pain assessments and sustained to week 64 @RheumNow Abstr#369
Dr. Antoni Chan synovialjoints
4 years ago
Secukinumab has been used to treat spinal involvement in axial SpA. Secukinumab led to significant improvements in symptoms of peripheral arthritis in pts with AS. Significant improvements were seen in both tender and swollen joints @RheumNow #ACR20 Abstr#366
Dr. John Cush RheumNow
4 years ago
Axial Involvement in Psoriatic Arthritis: Perspective by Dr. Eric Ruderman @JointMD
Dr. Eric Ruderman, Chicago, IL., provides his perspective on ACR 2020 coverage of axial involvement in Psoriatic Arthritis.
https://t.co/VwrQgirJnE
Dr Sarah Mackie Sarah_L_Mackie
4 years ago
@drdavidliew @MGHrheumatology @RheumNow That is so interesting. Haptoglobin first described by Paolaggi et al in early 1980s as having potential to monitor PMR/GCA even when ESR normalised. See link here...
https://t.co/ERkhUwssox
David Liew drdavidliew
4 years ago
If TCZ blunts CRP a lot/ESR a fair bit, how can we pick GCA relapses in pts on TCZ?
Cool tech (mass spec w tandem mass tag multiplex) on GiACTA samples. Of 344 candidate proteins, guess what ranked highest?
Haptoglobin.
Let's validate!
@MGHrheumatology #ACR20 ABST0513 @RheumNow https://t.co/ErmqZuf2iu
David Liew drdavidliew
4 years ago
@LCalabreseDO @cappelliMD @MarieKostine @EladSharonMD @rheum_covid For those who missed it, my attempt to capture some of it in a Twitter thread: https://t.co/Z55sV7ZyBt
Robert B Chao, MD doctorRBC
4 years ago
Tailoring treatment of psoriatic arthritis
#ACR20 @RheumNow
https://t.co/Ytv0vDrd95
Dr. Rachel Tate uptoTate
4 years ago
Check out my video on @rheumnow! #ACR20 Non-radiographic axSpa ACR Abstracts: Dr. Rachel Tate https://t.co/TVDdyZvOEA via @YouTube
Leonard Calabrese LCalabreseDO
4 years ago
Important study helping dissect the JAK-IFN axis I believe - we need to be cautious in attacking this axis as anifrolumab has >2x Zoster of JAKi's- we need to read the tea leaves from IEIs and COVID-19 #ACR20 @JYazdanyMD @Lupusdoc @casanova_lab @cannalab1 https://t.co/scI13jwFZd
Poster Hall